A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

NCT ID: NCT05310071

Last Updated: 2025-04-23

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE3

Total Enrollment

1027 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-02

Study Completion Date

2024-08-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) score as compared with placebo in participants with early Alzheimer's disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer's Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aducanumab

Participants will receive aducanumab, up to 10 milligrams per kilogram (mg/kg), monthly (once every four weeks), administered as intravenous (IV) infusion.

Group Type EXPERIMENTAL

Aducanumab

Intervention Type DRUG

Administered as specified in the treatment arm.

Placebo

Participants will receive placebo, monthly (once every four weeks), administered as IV infusion.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Administered as specified in the treatment arm.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aducanumab

Administered as specified in the treatment arm.

Intervention Type DRUG

Placebo

Administered as specified in the treatment arm.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

BIIB037 Aducanumab-avwa Aduhelm

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The participant must have confirmed amyloid beta pathology by cerebrospinal fluid (CSF) or amyloid PET
* Must have a history of subjective memory decline with gradual onset and slow progression over the 6 months before Screening, confirmed by study partner
* The participant must have 1 informant/care partner who, in the Investigator's opinion, has frequent and sufficient contact with the participant (at least 10 hours/week in person or by phone) as to be able to provide accurate information about the participant's cognitive and functional abilities over time
* Must meet all of the following clinical criteria for MCI due to Alzheimer's disease or mild Alzheimer's disease according to National Institute on Aging and Alzheimer's Association (NIA-AA) criteria

1. Have an MMSE score between 22 and 30 inclusive
2. Have a CDR memory score \>0.5
3. Have a Clinical Dementia Rating Scale Global Score (CDR-GS) of 0.5 or 1.0
4. Have a Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) score of 85 or lower indicative of objective cognitive impairment
* Apart from a clinical diagnosis of early Alzheimer's disease, the participant must be in good health as determined by the Investigator based on medical history and screening assessments
* Must consent to apolipoprotein E (ApoE) genotyping. (Note: Participants are not required to be ApoE ε4 carriers)

Exclusion Criteria

* Any uncontrolled medical or neurological/neurodegenerative condition (other than Alzheimer's disease) that, in the opinion of the Investigator, might be a contributing cause of the participant's cognitive impairment
* Clinically significant and/or unstable psychiatric illness within 6 months prior to Screening
* Transient ischemic attack or stroke or any unexplained loss of consciousness within 1 year prior to Screening
* History of severe allergic or anaphylactic reactions or of hypersensitivity to any of the inactive ingredients in the drug product
* Participation in any study with purported disease-modifying effect in Alzheimer's disease within 12 months prior to Screening unless documentation of receipt of placebo is available
* Current use or previous use of medications with a purported disease-modifying effect in Alzheimer's disease, outside of investigational studies
* Use of any medications that, in the opinion of the Investigator, may contribute to cognitive impairment, put the participant at higher risk for AEs, or impair the participant's ability to perform cognitive testing or complete study procedures
* Use of any investigational drug
* Prior exposure to aducanumab either commercially or by participation in a previous study with aducanumab. (Participants are eligible if they did not receive active aducanumab.)
* A negative PET scan result with any amyloid-targeting ligand within 12 months prior to Screening
Minimum Eligible Age

60 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Biogen

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Medical Director

Role: STUDY_DIRECTOR

Biogen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gilbert Neurology Partners, PLLC

Gilbert, Arizona, United States

Site Status

Xenoscience Inc.

Phoenix, Arizona, United States

Site Status

Banner Alzheimer's Institute

Phoenix, Arizona, United States

Site Status

Barrow Neurological Institute

Phoenix, Arizona, United States

Site Status

HonorHealth Neurology

Scottsdale, Arizona, United States

Site Status

Mayo Clinic Arizona

Scottsdale, Arizona, United States

Site Status

Banner Sun Health Research Institute

Sun City, Arizona, United States

Site Status

Banner Alzheimer's Institute

Tucson, Arizona, United States

Site Status

Health Initiatives Research

Fayetteville, Arkansas, United States

Site Status

Sun Valley Behaivoral Med Center

El Centro, California, United States

Site Status

Neuropain Medical Center

Fresno, California, United States

Site Status

Neurology Center of North Orange County

Fullerton, California, United States

Site Status

Irvine Center for Clinical Research, Inc.

Irvine, California, United States

Site Status

Mary S. Easton Center for Alzheimer's Disease Research, UCLA

Los Angeles, California, United States

Site Status

Hoag Memorial Hospital Presbyterian

Newport Beach, California, United States

Site Status

Stanford Hospital and Clinics

Palo Alto, California, United States

Site Status

VA Palo Alto Health Care System

Palo Alto, California, United States

Site Status

Anderson Clinical Research

Redlands, California, United States

Site Status

Sutter Health-San Francisco

San Francisco, California, United States

Site Status

University of California San Francisco (PARENT)

San Francisco, California, United States

Site Status

The Neuron Clinic

San Marcos, California, United States

Site Status

Syrentis Clinical Research

Santa Ana, California, United States

Site Status

California Neuroscience Research, LLC

Sherman Oaks, California, United States

Site Status

Viking Clinical Research Center

Temecula, California, United States

Site Status

University of Colorado Anschutz Medical Campus

Aurora, Colorado, United States

Site Status

Mountain Neurological Research Center

Basalt, Colorado, United States

Site Status

Yale University

Fairfield, Connecticut, United States

Site Status

Institute for Neurodegenerative Disorders (IND)

New Haven, Connecticut, United States

Site Status

Yale University School Of Medicine

New Haven, Connecticut, United States

Site Status

Research Center for Clinical Studies, Inc.

Norwalk, Connecticut, United States

Site Status

Howard University Health Sciences

Washington D.C., District of Columbia, United States

Site Status

Neurology of Central Florida Research Center, LLC

Altamonte Springs, Florida, United States

Site Status

JEM Research Institute

Atlantis, Florida, United States

Site Status

Neurology Offices of South Florida, PLLC

Boca Raton, Florida, United States

Site Status

ECommunity Research, LLC

Boca Raton, Florida, United States

Site Status

Nova Clinical Research, LLC

Bradenton, Florida, United States

Site Status

JY Research Institute

Cutler Bay, Florida, United States

Site Status

Brain Matters Research

Delray Beach, Florida, United States

Site Status

Neuropsychiatric Research Center of Southwest Florida

Fort Myers, Florida, United States

Site Status

Infinity Clinical Research, LLC

Hollywood, Florida, United States

Site Status

Charter Research, LLC

Lady Lake, Florida, United States

Site Status

ARS - Lake Oconee

Lakeland, Florida, United States

Site Status

Medical Research Center

Miami, Florida, United States

Site Status

Renstar Medical Research

Ocala, Florida, United States

Site Status

K2 Medical Research, LLC

Ocoee, Florida, United States

Site Status

K2 Medical Research, LLC

Orlando, Florida, United States

Site Status

K2 Medical Research

Orlando, Florida, United States

Site Status

Headlands Research LLC

Orlando, Florida, United States

Site Status

Conquest Research

Orlando, Florida, United States

Site Status

Quantum Laboratories Inc.

Pompano Beach, Florida, United States

Site Status

United Medical Research

Port Orange, Florida, United States

Site Status

Brain Matters Research

Stuart, Florida, United States

Site Status

K2 Medical Research Tampa

Tampa, Florida, United States

Site Status

USF Health Byrd Institute

Tampa, Florida, United States

Site Status

Hawaii Pacific Neuroscience

Honolulu, Hawaii, United States

Site Status

Great Lakes Clinical Trials, LLC Ravenswood dba Flourish Research

Chicago, Illinois, United States

Site Status

University of Chicago Medical Center

Chicago, Illinois, United States

Site Status

Alexian Brothers Medical Center - Neuroscience Research Institute

Elk Grove Village, Illinois, United States

Site Status

Indiana University School of Medicine

Indianapolis, Indiana, United States

Site Status

University of Kansas Medical Center Research Institute, Inc.

Fairway, Kansas, United States

Site Status

Ascension Via Christi Research, a division of Ascension Via Christi Hospitals Wichita, Inc.

Wichita, Kansas, United States

Site Status

University of Kentucky Medical Center

Lexington, Kentucky, United States

Site Status

Ochsner Health System PARENT

New Orleans, Louisiana, United States

Site Status

LSU Health Sciences Center Shreveport

Shreveport, Louisiana, United States

Site Status

University of Maryland Medical Center

Baltimore, Maryland, United States

Site Status

McLean Hospital

Belmont, Massachusetts, United States

Site Status

Brigham and Women's Hospital Department of Neurology

Boston, Massachusetts, United States

Site Status

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

Site Status

ActivMed Practices and Research

Methuen, Massachusetts, United States

Site Status

Boston Center for Memory

Newton, Massachusetts, United States

Site Status

Donald S. Marks, M.D., P.C.

Plymouth, Massachusetts, United States

Site Status

Wayne State University - Detroit Medical Center

Detroit, Michigan, United States

Site Status

Michigan Institute for Neurological Disorders

Farmington Hills, Michigan, United States

Site Status

Center for Memory and Aging

Saint Paul, Minnesota, United States

Site Status

Hattiesburg Clinic, PA

Hattiesburg, Mississippi, United States

Site Status

Sharlin Health and Neurology

Ozark, Missouri, United States

Site Status

University of Nebraska Medical Center

Omaha, Nebraska, United States

Site Status

Cleveland Clinic Lou Ruvo Center for Brain Health

Las Vegas, Nevada, United States

Site Status

Las Vegas Medical Research

Las Vegas, Nevada, United States

Site Status

The Cognitive Research Center of New Jersey

Springfield, New Jersey, United States

Site Status

CenExel Advanced Memory Research Institute of NJ

Toms River, New Jersey, United States

Site Status

Neurological Associates of Albany, PC

Albany, New York, United States

Site Status

Dent Neurologic Institute

Amherst, New York, United States

Site Status

Social Psychiatry Research Institute (SPRI)

Brooklyn, New York, United States

Site Status

New York University Medical Center PRIME

New York, New York, United States

Site Status

Mount Sinai

New York, New York, United States

Site Status

South Shore Neurologic Associates, P.C.

Patchogue, New York, United States

Site Status

Finger Lakes Clinical Research

Rochester, New York, United States

Site Status

University of Rochester - PARENT

Rochester, New York, United States

Site Status

Richmond Behavioral Associates ERG Clinical Research - New York PLLC

Staten Island, New York, United States

Site Status

Stony Brook University Hospital

Stony Brook, New York, United States

Site Status

SUNY Upstate Medical University

Syracuse, New York, United States

Site Status

IMA Evaluations LLC

Tarrytown, New York, United States

Site Status

Duke University

Durham, North Carolina, United States

Site Status

AMC Research, LLC

Matthews, North Carolina, United States

Site Status

Wake Forest Baptist Health Sciences

Winston-Salem, North Carolina, United States

Site Status

Cleveland Clinic Foundation

Cleveland, Ohio, United States

Site Status

Ohio State University Medical Center

Columbus, Ohio, United States

Site Status

Neuro-Behavioral Clinical Research, Inc.

North Canton, Ohio, United States

Site Status

Lynn Health Science Institute

Oklahoma City, Oklahoma, United States

Site Status

Central States Research, LLC

Tulsa, Oklahoma, United States

Site Status

Oregon Health & Science University (OHSU)

Portland, Oregon, United States

Site Status

Abington Neurological Associates, LTD

Abington, Pennsylvania, United States

Site Status

The Clinical Trial Center, LLC

Jenkintown, Pennsylvania, United States

Site Status

Penn Memory Center

Philadelphia, Pennsylvania, United States

Site Status

Rhode Island Hospital

East Providence, Rhode Island, United States

Site Status

Rhode Island Mood & Memory Research Institute

East Providence, Rhode Island, United States

Site Status

Butler Hospital

Providence, Rhode Island, United States

Site Status

Coastal Neurology PA

Port Royal, South Carolina, United States

Site Status

Neurology Clinic, PC

Cordova, Tennessee, United States

Site Status

Genesis Neuroscience Clinic

Knoxville, Tennessee, United States

Site Status

Senior Adult Specialty Research

Austin, Texas, United States

Site Status

Headlands Research - Brownsville

Brownsville, Texas, United States

Site Status

Kerwin Medical Center

Dallas, Texas, United States

Site Status

UT Southwestern Medical Center

Dallas, Texas, United States

Site Status

University of North Texas Health Science Center

Fort Worth, Texas, United States

Site Status

Baylor College Of Medicine

Houston, Texas, United States

Site Status

The Methodist Hospital Research Institute

Houston, Texas, United States

Site Status

Clinical Trial Network LLC

Houston, Texas, United States

Site Status

Central Texas Neurology Consultants

Round Rock, Texas, United States

Site Status

University of Texas Health Science Center at San Antonio

San Antonio, Texas, United States

Site Status

The Memory Clinic

Bennington, Vermont, United States

Site Status

University of Virginia Health System

Charlottesville, Virginia, United States

Site Status

Glennan Center for Geriatrics and Gerontology

Norfolk, Virginia, United States

Site Status

National Clinical Research Inc. - Richmond

Richmond, Virginia, United States

Site Status

University of Washington Medical Center

Seattle, Washington, United States

Site Status

Kingfisher Cooperative, LLC

Spokane, Washington, United States

Site Status

University of Wisconsin-Madison

Madison, Wisconsin, United States

Site Status

Marshfield Clinic

Marshfield, Wisconsin, United States

Site Status

Medical College of Wisconsin, Inc.

Milwaukee, Wisconsin, United States

Site Status

St Vincent's Hospital Sydney

Darlinghurst, New South Wales, Australia

Site Status

KaRa Institute of Neurological Diseases

Macquarie Park, New South Wales, Australia

Site Status

Box Hill Hospital

Box Hill, Victoria, Australia

Site Status

Frankston Hospital

Frankston, Victoria, Australia

Site Status

Austin Health

Heidelberg, Victoria, Australia

Site Status

The Alfred Hospital

Melbourne, Victoria, Australia

Site Status

Royal Melbourne Hospital

Parkville, Victoria, Australia

Site Status

Australian Alzheimer's Research Foundation

Nedlands, Western Australia, Australia

Site Status

UZ Leuven

Leuven, Flemish Brabant, Belgium

Site Status

AZ Sint-Jan

Bruges, , Belgium

Site Status

Universitair Ziekenhuis Brussel

Brussels, , Belgium

Site Status

AZ Groeninge

Kortrijk, , Belgium

Site Status

Trial Tech Tecnologia em Pesquisas com Medicamentos Ltda

Curitiba, Paraná, Brazil

Site Status

Instituto de Neurologia de Curitiba - Hospital Ecoville

Curitiba, Paraná, Brazil

Site Status

IMV Pesquisa Neurologica Sociedade Simples Ltda

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Instituto do Cerebro do Rio Grande do Sul

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

IPq-HCFMUSP - Instituto de Psiquiatria do Hospital das Clínicas da FMUSP

São Paulo, São Paulo, Brazil

Site Status

University of Calgary - Heritage Medical Research Clinic

Calgary, Alberta, Canada

Site Status

UBC Hospital

Vancouver, British Columbia, Canada

Site Status

Centricity Research Halifax

Halifax, Nova Scotia, Canada

Site Status

Recherches Neuro-Hippocampe Inc., d/b/a Ottawa Memory Clinic

Ottawa, Ontario, Canada

Site Status

Kawartha Centre - Redefining Healthy Aging

Peterborough, Ontario, Canada

Site Status

Toronto Memory Program (Neurology Research Inc.)

Toronto, Ontario, Canada

Site Status

Centricity Research Toronto LMC

Toronto, Ontario, Canada

Site Status

Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada

Site Status

Toronto Western Hospital

Toronto, Ontario, Canada

Site Status

Baycrest Centre for Geriatric Care

Toronto, Ontario, Canada

Site Status

Clinique de la Memoire de l'Outaouais

Gatineau, Quebec, Canada

Site Status

MoCA Research and Innovation Inc

Greenfield Park, Quebec, Canada

Site Status

Montreal Neurological Institute Clinical Research Unit

Montreal, Quebec, Canada

Site Status

CHU de Quebec- Hopital de l Enfant Jesus

Québec, , Canada

Site Status

Terveystalo Ruoholahti

Helsinki, , Finland

Site Status

CRST, Clinical Research Services Turku

Turku, , Finland

Site Status

CHU Strasbourg - Hôpital Hautepierre

Strasbourg, Bas Rhin, France

Site Status

Hôpital de la Timone

Marseille, Bouches-du-Rhône, France

Site Status

Groupe Hospitalier Pellegrin - Hôpital Pellegrin

Bordeaux, Gironde, France

Site Status

Hôpital La Grave

Toulouse, Haute Garonne, France

Site Status

Hopital Gui de Chauliac

Montpellier, Herault, France

Site Status

CHU Rennes - Pontchaillou

Rennes, Ille Et Vilaine, France

Site Status

CHU Nantes - Hopital Nord Laënnec

Saint-Herblain, Loire Atlantique, France

Site Status

Hopital Roger Salengro - CHU Lille

Lille, Nord, France

Site Status

Hôpital Lariboisière

Paris, Paris, France

Site Status

Hôpital des Chapennes

Villeurbanne, Rhone, France

Site Status

Groupe Hospitalier Pitie-Salpetriere

Paris, , France

Site Status

Hôpital Broca

Paris, , France

Site Status

Universitaetsklinikum Freiburg

Freiburg im Breisgau, Baden-Wurttemberg, Germany

Site Status

ISPG - Institut fuer Studien zur Psychischen Gesundheit

Mannheim, Baden-Wurttemberg, Germany

Site Status

Universitaetsklinikum Tuebingen

Tübingen, Baden-Wurttemberg, Germany

Site Status

Klinikum Bayreuth GmbH- Hohe Warte

Bayreuth, Bavaria, Germany

Site Status

Institut fuer Schlaganfall- und Demenzforschung (ISD)

Munich, Bavaria, Germany

Site Status

Klinikum rechts der Isar der TU Muenchen

Munich, Bavaria, Germany

Site Status

Zentrum für klinische Forschung Dr.med. Irma Schöll

Bad Homburg, Hesse, Germany

Site Status

Universitaetsklinikum Frankfurt Goethe-Universitaet

Frankfurt am Main, Hesse, Germany

Site Status

Universitaetsmedizin Goettingen

Göttingen, Lower Saxony, Germany

Site Status

Universitaetsmedizin Greifswald

Greifswald, Mecklenburg-Vorpommern, Germany

Site Status

Katholisches Klinikum Bochum gGmbH

Bochum, North Rhine-Westphalia, Germany

Site Status

Deutsches Zentrum fuer Neurodegenerative Erkrankungen (DZNE)

Bonn, North Rhine-Westphalia, Germany

Site Status

Universitaetsklinikum Koeln

Cologne, North Rhine-Westphalia, Germany

Site Status

Universitaetsklinikum Duesseldorf AoeR

Düsseldorf, North Rhine-Westphalia, Germany

Site Status

Universitaetsklinikum Carl Gustav Carus TU Dresden

Dresden, Saxony, Germany

Site Status

Universitaetsklinikum Magdeburg

Magdeburg, Saxony-Anhalt, Germany

Site Status

NEUROZENTRUM tempelhof.berlin

Berlin, , Germany

Site Status

Charité - Universitätsmedizin Berlin

Berlin, , Germany

Site Status

Azienda Ospedaliera Card. G. Panico

Tricase, Lecce, Italy

Site Status

ASST di Monza

Monza, Milano, Italy

Site Status

Fondazione Istituto G.Giglio di Cefalù

Cefalù, Palermo, Italy

Site Status

Ospedale di Arzignano

Arzignano VI, Vicenza, Italy

Site Status

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili)

Brescia, , Italy

Site Status

IRCCS Ospedale Policlinico San Martino

Genova, , Italy

Site Status

Ospedale San Raffaele

Milan, , Italy

Site Status

Azienda Ospedaliera Universitaria- Università degli Studi della Campania "Luigi Vanvitelli"

Napoli, , Italy

Site Status

Azienda Ospedaliera e Universitaria di Perugia

Perugia, , Italy

Site Status

Fondazione Santa Lucia IRCCS

Roma, , Italy

Site Status

Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza

Roma, , Italy

Site Status

Azienda Ospedaliera Universitaria OO. RR. S. Giovanni di Dio e Ruggi D'Aragona

Salerno, , Italy

Site Status

National Center For Geriatrics And Gerontology

Obu-shi, Aichi-ken, Japan

Site Status

Hakuyokai Kashiwado Hospital

Chiba, Chiba, Japan

Site Status

Inage Neurology and Memory Clinic

Chiba, Chiba, Japan

Site Status

Southern Tohoku Medical Clinic

Koriyama-shi, Fukushima, Japan

Site Status

NHO Hiroshima-Nishi Medical Center

Otake-shi, Hiroshima, Japan

Site Status

Himeji Central Hospital Clinic

Himeji-shi, Hyōgo, Japan

Site Status

Kagawa University Hospital

Kita-gun, Kagawa-ken, Japan

Site Status

Tokushukai Shonan Atsugi Hospital

Atsugi-shi, Kanagawa, Japan

Site Status

Tokushukai Shonan Kamakura General Hospital

Kamakura-shi, Kanagawa, Japan

Site Status

Teikyo University Hospital, Mizonokuchi

Kawasaki-shi, Kanagawa, Japan

Site Status

Rakuwakai Otowa Rehabilitation Hospital

Kyoto, Kyoto, Japan

Site Status

NHO Utano National Hospital

Kyoto, Kyoto, Japan

Site Status

Katayama Medical Clinic

Kurashiki-shi, Okayama-ken, Japan

Site Status

Tokushukai Kishiwada Tokushukai Hospital

Kishiwada-shi, Osaka, Japan

Site Status

Osaka University Hospital

Suita-shi, Osaka, Japan

Site Status

Midorikai Takesato Hospital

Kasukabe-shi, Saitama, Japan

Site Status

Memory Clinic Ochanomizu

Bunkyō City, Tokyo-To, Japan

Site Status

National Center of Neurology and Psychiatry

Kodaira-shi, Tokyo-To, Japan

Site Status

Tokushukai Yamagata Tokushukai Hospital

Yamagata, Yamagata, Japan

Site Status

Hospital Mexico Americano SC

Guadalara, Jalisco, Mexico

Site Status

Health Pharma Professional Research S.A. de C.V.

Mexico City, Mexico City, Mexico

Site Status

Hospital Universitario Dr. Jose Eleuterio Gonzalez

Monterrey, Nuevo León, Mexico

Site Status

Centro de Estudios Clinicos y Especialidades Medicas, S.C.

Monterrey, Nuevo León, Mexico

Site Status

AVIX Investigación Clínica S.C

Monterrey, Nuevo León, Mexico

Site Status

PROMENTE Sp. z o.o.

Bydgoszcz, Kujawsko-Pomorskie Województwo, Poland

Site Status

Centrum Medyczne NeuroProtect

Warsaw, Mazowieckie Województwo, Poland

Site Status

Podlaskie Centrum Psychogeriatrii

Bialystok, Podkarpackie Wojewódctwo, Poland

Site Status

Centrum Medyczne Senior

Sopot, Pomorskie Województwo, Poland

Site Status

Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie Kliniczny Oddział Neurologii Oddział Udarowy

Lublin, , Poland

Site Status

NZOZ Wroclawskie Centrum Alzheimerowskie

Wroclaw, , Poland

Site Status

Nzoz Novo-Med

Katowice, Śląskie Województwo, Poland

Site Status

Neuro-Care Gabriela Klodowska

Siemianowice Śląskie, Śląskie Województwo, Poland

Site Status

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

Site Status

Konkuk University Medical Center

Seoul, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

Hospital Universitario Reina Sofia

Córdoba, Córdoba, Spain

Site Status

Policlinica Gipuzkoa

Donostia / San Sebastian, Guipuzcoa, Spain

Site Status

Clinica Universidad de Navarra

Pamplona, Navarre, Spain

Site Status

Fundacio ACE

Barcelona, , Spain

Site Status

Hospital Clinic de Barcelona

Barcelona, , Spain

Site Status

Hospital de la Santa Creu i Sant Pau

Barcelona, , Spain

Site Status

Hospital Universitari de Santa Maria

Lleida, , Spain

Site Status

Clinica Universidad de Navarra (MAD)

Madrid, , Spain

Site Status

Hospital Victoria Eugenia

Seville, , Spain

Site Status

Hospital Universitario Dr. Peset

Valencia, , Spain

Site Status

Hospital Universitari i Politecnic La Fe

Valencia, , Spain

Site Status

Skane University Hospital

Malmo, Skåne County, Sweden

Site Status

Sahlgrenska Universitetssjukhuset, Mölndal Sjukhus

Mölndal, Västra Götaland County, Sweden

Site Status

Karolinska Universitetssjukhuset

Stockholm, , Sweden

Site Status

The University of Edinburgh

Edinburgh, East Lothian, United Kingdom

Site Status

Institute of Psychiatry, Psychology and Neuroscience

London, Greater London, United Kingdom

Site Status

Re:Cognition Health Ltd (London)

London, Greater London, United Kingdom

Site Status

Charing Cross Hospital

London, Greater London, United Kingdom

Site Status

Park House

Manchester, Greater Manchester, United Kingdom

Site Status

Southampton General Hospital

Southampton, Hampshire, United Kingdom

Site Status

Moorgreen Hospital

Southampton, Hampshire, United Kingdom

Site Status

Brain Health Scotland Life Sciences

Edinburgh, Lothian Region, United Kingdom

Site Status

The RICE Centre

Bath, Somerset, United Kingdom

Site Status

Glasgow Memory Clinic Ltd

Motherwell, Strathclyde, United Kingdom

Site Status

Re Cognition Health Bristol

Bristol, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Belgium Brazil Canada Finland France Germany Italy Japan Mexico Poland South Korea Spain Sweden United Kingdom

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-001671-14

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

221AD305

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study of AV-1959D, an Amyloid Beta Vaccine
NCT05642429 ACTIVE_NOT_RECRUITING PHASE1